BioForm Prices Low IPO

BioForm Medical Inc., a San Mateo, Calif.-based developer of an injectable dermal filler for aesthetic improvement, raised $80 million through its IPO. The company priced 10 million common shares at $8 per share ($9-$11 range), for an initial market cap of approximately $357 million. It will trade on the Nasdaq under ticker symbol BFRM, while JPMorgan and Piper Jaffray served as co-lead underwriters.

 

The company had raised nearly $65 million in total VC funding since 2000, from firms like Essex Woodlands Health Ventures (20.5% pre-IPO stake), PTV Sciences (18.3%), Vivo Ventures (15.4%), Veron International Ltd. (9.6%) and Teknoinvest (9.1%). www.bioforminc.com